JANE STREET GROUP, LLC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 114 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2018. The put-call ratio across all filers is 0.86 and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2018$113,000
-64.2%
11,161
-66.0%
0.00%
-100.0%
Q4 2017$316,000
+146.9%
32,858
+201.5%
0.00%0.0%
Q3 2016$128,000
-62.1%
10,899
-7.6%
0.00%
-50.0%
Q4 2015$338,000
-72.1%
11,796
-72.3%
0.00%
-75.0%
Q3 2015$1,213,000
+6.5%
42,615
+34.4%
0.01%0.0%
Q2 2015$1,139,000
+408.5%
31,707
+722.1%
0.01%
+300.0%
Q1 2015$224,000
-28.0%
3,857
-47.7%
0.00%0.0%
Q4 2014$311,000
+45.3%
7,370
+33.5%
0.00%0.0%
Q3 2014$214,0005,5200.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q3 2018
NameSharesValueWeighting ↓
Consonance Capital Management LP 3,257,094$92,697,00013.04%
JW Asset Management, LLC 388,346$11,052,0004.00%
Anson Funds Management LP 400,200$11,390,0003.31%
Orbimed Advisors 4,081,800$116,168,0001.17%
SCOPIA CAPITAL MANAGEMENT LP 1,718,487$48,908,0001.05%
Bellevue Asset Management AG 210,000$5,977,0000.98%
NEXT CENTURY GROWTH INVESTORS LLC 788,534$22,441,0000.93%
Rock Springs Capital Management LP 308,000$8,766,0000.71%
JUNCTURE WEALTH STRATEGIES, LLC 18,502$527,0000.43%
B. Riley Wealth Management, Inc. 8,600$244,0000.35%
View complete list of INSYS THERAPEUTICS INC NEW shareholders